Foresite Capital Management IV, LLC — 13F holdings

Foresite Capital Management IV, LLC reported 6 holdings worth $290M in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. PHVS PHARVARIS N V — $165M (57.0%)
2. CYTK CYTOKINETICS INC — $60.9M (21.0%)
3. EIKN EIKON THERAPEUTICS INC — $25.4M (8.7%)
4. RLAY RELAY THERAPEUTICS INC — $23.4M (8.1%)
5. XENE XENON PHARMACEUTICALS INC — $9.66M (3.3%)
6. CRINETICS PHARMACEUTICALS IN — $5.61M (1.9%)